Indicators

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2 3 4 5 6 7 8 9

...

Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories

May 17, 2023

Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows

May 17, 2023

AI Meets Biotech: Transforming the Drug Development Process

May 16, 2023

3 Stocks That Are Reshaping the Future

May 16, 2023

3 Personalized Medicine Stocks to Buy for Long-Time Returns

May 15, 2023

EXCLUSIVE: SAB Biotherapeutics' Influenza Immunotherapy Shows Safety, Efficacy In Early-Stage Trials

May 04, 2023

Tempest Therapeutics' TPST-1120 Shines In Early Phase 1b/2 Study: Analysts Get Bullish

April 28, 2023

Roche's Q1 Highlights: Increased Uptake Of Eye Disease Drug Cushions Sales Decline

April 26, 2023

EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial

April 26, 2023

3 Top Biotech Stocks Defying the Bear Market

April 25, 2023

This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health

April 25, 2023

FDA Approves Roche's Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma

April 20, 2023

EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics' Influenza Antibody

April 13, 2023

Why Shares of Adaptimmune Therapeutics Jumped Tuesday

April 11, 2023

Bolt Biotherapeutics Says Phase 1 Data Supports Advancing Into Phase 2 Studies

March 30, 2023

Roche's Slow Growth Shouldn't Drive Investors Away

March 28, 2023

Roche Joins Hand With Lilly To Improve Early Diagnosis Of Alzheimer's Disease

March 22, 2023

New Four Year Data For Roche's Evrysdi Reinforces Long-Term Efficacy, Safety Profile In Muscular Atrophy Patients

March 20, 2023

Is Roche a Buy Now?

March 20, 2023

Sarepta Plunges As FDA Takes Surprise Turn; AdComm Meeting Set For Duchenne Gene Therapy

March 17, 2023

FDA Casts Doubts Over Roche's Polivy Label Expansion For Untreated Lymphoma Setting

March 09, 2023

The Top 7 Growth Stocks in Biotech

March 03, 2023

Roche, Exelixis Report Second Flop Out Of Three Trials Evaluating Cabozantinib/Atezolizumab Combo

March 03, 2023

Why Sarepta Therapeutics' Shares Rose 23.4% This Week

March 02, 2023

3 Best Growth Stocks to Buy In March

March 02, 2023

Blueprint Medicines Highlights Detailed Data From Lead Product In Blood Cancer Patients

February 27, 2023

Roche Decides To Terminate Cancer Treatment Pact With Blueprint Medicines

February 23, 2023

Infinity Pharmaceuticals Announce Merger Agreement With MEI Pharma, Share Plunge

February 23, 2023

New Data Shows Roche's Vabysmo Improves Vision, Retinal Fluid In Retinal Disorder

February 10, 2023

Roche Touts Positive Crovalimab Data From Late-Stage Study In Rare Blood Condition

February 07, 2023

< Previous 1 2 3 4 5 6 7 8 9

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.